KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Other Working Capital Changes (2016 - 2025)

Vertex Pharmaceuticals has reported Other Working Capital Changes over the past 17 years, most recently at $250.6 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $250.6 million for Q4 2025, up 52.25% from a year ago — trailing twelve months through Dec 2025 was $396.0 million (up 97.7% YoY), and the annual figure for FY2025 was $396.0 million, up 97.7%.
  • Other Working Capital Changes for Q4 2025 was $250.6 million at Vertex Pharmaceuticals, up from $40.9 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for VRTX hit a ceiling of $451.3 million in Q4 2023 and a floor of -$99.2 million in Q1 2024.
  • Median Other Working Capital Changes over the past 5 years was $34.5 million (2025), compared with a mean of $78.0 million.
  • Peak annual rise in Other Working Capital Changes hit 1889.31% in 2022, while the deepest fall reached 608.27% in 2022.
  • Vertex Pharmaceuticals' Other Working Capital Changes stood at -$15.9 million in 2021, then soared by 1889.31% to $284.5 million in 2022, then surged by 58.63% to $451.3 million in 2023, then tumbled by 63.53% to $164.6 million in 2024, then skyrocketed by 52.25% to $250.6 million in 2025.
  • The last three reported values for Other Working Capital Changes were $250.6 million (Q4 2025), $40.9 million (Q3 2025), and $76.4 million (Q2 2025) per Business Quant data.